This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Explore which is better: real estate or stock market. Find the investment fit that aligns with your financial objectives.
28,586 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
Defiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
A long-running insurer broker, founded in 1941, has quietly raised its dividends for decades and now offers a compell...
A long-dormant market indicator has flashed, raising questions about the pace of the rally as the midterm election cy...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
The healthcare sector is showing unexpected strength, beat-the-market moves, and renewed investor interest. This guid...
A new market dynamic shows Bitcoin ETF assets can shrink without investors selling, as mark-to-market losses mute the...
Private credit funds are tightening access to withdrawals through redemption limits. This article explains the mechan...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
A focused bet on telecom infrastructure amid sector volatility shows how savvy funds seek durable cash flow. Explore ...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...